scholarly journals Final efficacy and safety data, and exploratory molecular profiling from the phase III ALUR study of alectinib versus chemotherapy in crizotinib-pretreated ALK-positive non-small-cell lung cancer

ESMO Open ◽  
2022 ◽  
Vol 7 (1) ◽  
pp. 100333
Author(s):  
J. Wolf ◽  
Å. Helland ◽  
I.-J. Oh ◽  
M.R. Migliorino ◽  
R. Dziadziuszko ◽  
...  
2017 ◽  
Vol 12 (1) ◽  
pp. S378 ◽  
Author(s):  
D. Ross Camidge ◽  
Shirish Gadgeel ◽  
Sai-Hong Ou ◽  
Leena Gandhi ◽  
Gregory Riely ◽  
...  

2017 ◽  
Vol 12 (1) ◽  
pp. S378-S379 ◽  
Author(s):  
Young Kim ◽  
Toyoaki Hida ◽  
Hiroshi Nokihara ◽  
Masashi Kondo ◽  
Koichi Azuma ◽  
...  

2012 ◽  
Vol 23 ◽  
pp. ix438-ix439
Author(s):  
J. Zugazagoitia ◽  
J. Puente ◽  
S. Hernandez ◽  
J.L. Gonzalez-Larriba ◽  
J. Sanz ◽  
...  

Lung Cancer ◽  
2012 ◽  
Vol 77 (2) ◽  
pp. 339-345 ◽  
Author(s):  
Yi-Long Wu ◽  
Joo-Hang Kim ◽  
Keunchil Park ◽  
Adel Zaatar ◽  
Gaëlle Klingelschmitt ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document